BiotechTube
Home/Medannex/Dr Lisa Yule
DL

Dr Lisa Yule

Head of Regulatory

Medannex

Therapeutic Areas

OncologyAutoimmune Diseases

Medannex Pipeline

DrugIndicationPhase
MDX-124Advanced Solid Tumors (including Biliary Tract Cancer)Phase 1b

Leadership Team at Medannex

PC
Prof Christopher Wood
Executive Chairman & Founder
IA
Ian Abercrombie
Chief Executive Officer
DF
Dr Fiona Dempsey
Director of Scientific Operations
CT
Colin Tennant
Project Director
JI
James Ingham
Operations Director
DH
Dr Henry Hays
Project Manager
View full Medannex profile